The emergence of 4D Bioprinting: Next Generation in regenerative medicine & human-machine interfacing

An overview of the 4D bioprinting industry and its potential impact on regenerative medicine and human-machine interfaces to diagnose, monitor and treat a wide range of diseases. Novel emerging biofabrication technologies and biomaterials with superior advantages such as nanoscale resolution & cells reaching high viability whilst maintaining metabolic and pluripotent characteristics.

Presented by Stephen Gray, Co-Founder: Advanced 4D Bioprinting, Cyborganics,& Human-Machine Interface Technology, Ourobionics.


Question 1: What drives you?
I have witnessed family members suffer from degenerative diseases such as Parkinson’s. As a result I am driven to build new 4D Bioprinting technologies in regenerative medicine and human-machine interfacing to create the next frontier of solutions for degenerative diseases

Question 2: Why should the delegate attend your presentation?
To gain more insight into the emergence of the new 4D Bioprinting Industry and how it can impact other sectors and transform the healthcare Industry

Question 3: What emerging technologies / trends do you see as having the greatest potential in the short and long run?
3D Electric, Magnetic, & Microfluidic biofabrication technologies that are proven to overcome all of the limitations of extrusion bioprinting. Additionally the evolution of self assembling, electroconductive, biosensing and self healing biomaterials.

Question 4: What kind of impact do you expect them to have?
To create next generation solutions for the healthcare industry

Question 5: What are the barriers that might stand in the way?
We still need to test the limitations of these new technologies but also it takes more than one advanced technology to transform the industry so the mergence of the biofabrication and biomaterials is an important step.

About Ourobionics
We are the first start-up to merge advanced electric, magnetic, & microfluidic 3D biofabrication technology with novel cyborganic technology to create high throughput tissues & organs with embedded bioelectronics, biosensors, and therapeutic agents.
We go beyond bioprinting to establish next generation applications in regenerative medicine, medical devices, & human-machine interfaces.

We believe that increasing the number of advanced hybrid technologies available for commercial use will set the new quality benchmark of biofabricated products and unlock new, more complex applications in tissue engineering and regenerative medicine. Novel applications include cyborganics, biomechatronics, biosensors, biorobotics, and human-machine interfaces.

By developing and supplying up-to-date, cutting-edge technologies in biofabrication and tissue engineering, we want to offer complete, standardized processes to our customers and make the field of biofabrication more accessible to any working professional with a vision. We empower researchers, developers and producers in various promising fields, thus facilitating their journey from the lab benchtop to the market.

Stephen Gray is speaker at the 2022 edition of the 3D Bioprinting Conference.

Leave a Reply

Your email address will not be published.